PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $339,105 | -18.5% | 11,053 | +6.4% | 0.00% | 0.0% |
| Q2 2023 | $416,286 | -9.9% | 10,389 | -8.2% | 0.00% | 0.0% |
| Q1 2023 | $462,051 | -0.1% | 11,322 | -5.5% | 0.00% | 0.0% |
| Q4 2022 | $462,548 | -33.2% | 11,980 | -7.8% | 0.00% | 0.0% |
| Q3 2022 | $692,000 | -16.6% | 12,995 | -8.7% | 0.00% | -50.0% |
| Q2 2022 | $830,000 | -35.5% | 14,239 | -15.5% | 0.00% | 0.0% |
| Q1 2022 | $1,286,000 | +31.6% | 16,847 | +3.8% | 0.00% | 0.0% |
| Q4 2021 | $977,000 | +12.4% | 16,233 | +4.6% | 0.00% | 0.0% |
| Q3 2021 | $869,000 | +4.2% | 15,513 | +12.7% | 0.00% | 0.0% |
| Q2 2021 | $834,000 | -9.9% | 13,759 | +4.2% | 0.00% | 0.0% |
| Q1 2021 | $926,000 | +15.2% | 13,210 | -1.8% | 0.00% | 0.0% |
| Q4 2020 | $804,000 | +8.5% | 13,457 | +9.1% | 0.00% | 0.0% |
| Q3 2020 | $741,000 | +47.0% | 12,333 | +28.4% | 0.00% | +100.0% |
| Q2 2020 | $504,000 | +163.9% | 9,606 | +68.4% | 0.00% | 0.0% |
| Q1 2020 | $191,000 | -26.8% | 5,704 | -0.9% | 0.00% | 0.0% |
| Q4 2019 | $261,000 | +210.7% | 5,756 | +161.8% | 0.00% | – |
| Q3 2019 | $84,000 | -55.8% | 2,199 | -49.7% | 0.00% | -100.0% |
| Q2 2019 | $190,000 | +25.0% | 4,373 | +9.4% | 0.00% | – |
| Q1 2019 | $152,000 | -9.0% | 3,998 | +3.0% | 0.00% | -100.0% |
| Q4 2018 | $167,000 | -1.2% | 3,881 | +12.6% | 0.00% | – |
| Q3 2018 | $169,000 | -12.9% | 3,446 | -42.9% | 0.00% | -100.0% |
| Q2 2018 | $194,000 | +44.8% | 6,038 | +40.7% | 0.00% | – |
| Q1 2018 | $134,000 | +5.5% | 4,292 | +53.8% | 0.00% | – |
| Q4 2017 | $127,000 | +25.7% | 2,791 | +3.8% | 0.00% | – |
| Q3 2017 | $101,000 | -13.7% | 2,688 | +9.7% | 0.00% | – |
| Q2 2017 | $117,000 | -71.5% | 2,451 | -72.7% | 0.00% | -100.0% |
| Q1 2017 | $410,000 | +112.4% | 8,989 | +50.5% | 0.00% | 0.0% |
| Q4 2016 | $193,000 | -21.9% | 5,974 | -17.3% | 0.00% | 0.0% |
| Q3 2016 | $247,000 | +46.2% | 7,220 | +44.1% | 0.00% | 0.0% |
| Q2 2016 | $169,000 | -30.7% | 5,010 | +8.5% | 0.00% | 0.0% |
| Q1 2016 | $244,000 | -8.6% | 4,616 | +32.8% | 0.00% | 0.0% |
| Q4 2015 | $267,000 | +304.5% | 3,477 | +115.3% | 0.00% | – |
| Q3 2015 | $66,000 | -50.4% | 1,615 | -14.5% | 0.00% | -100.0% |
| Q2 2015 | $133,000 | -26.5% | 1,889 | -7.6% | 0.00% | 0.0% |
| Q1 2015 | $181,000 | -47.5% | 2,045 | -47.4% | 0.00% | 0.0% |
| Q4 2014 | $345,000 | +143.0% | 3,887 | +165.9% | 0.00% | 0.0% |
| Q3 2014 | $142,000 | +108.8% | 1,462 | +98.9% | 0.00% | – |
| Q2 2014 | $68,000 | +134.5% | 735 | +79.3% | 0.00% | – |
| Q1 2014 | $29,000 | -78.5% | 410 | -82.6% | 0.00% | -100.0% |
| Q4 2013 | $135,000 | -15.6% | 2,350 | -29.0% | 0.00% | 0.0% |
| Q3 2013 | $160,000 | +171.2% | 3,312 | +61.6% | 0.00% | – |
| Q2 2013 | $59,000 | – | 2,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |